日本生產流感疫苗

Recently Yahoo News reported the following:

新型インフルエンザ 対策で、国内ワクチンメーカーの生產が本格化している。 財団法人化學及血清療法研究所 (化血研, 熊本市)は２５日までに、製造過程の写真を公開、担当者は「生產に最大限努力したい」としている。厚生労働省によると、国内メーカー４社のうち、化血研が２４日、別の１社が２０日に生產を開始しており、ほかの２社も８月中に後に続く。来年２月まで 製造を続けた場合、計約２３０００万～３0000万人分が用意される見通し。接種希望者が多ければ、同省は輸入も検討する。

In response to the new type influenza, vaccine production in the country is now in place. A research center on 25th has released its photo on its vaccine making and undertakes to give the best effort in its production. According to the Ministry of Health, Welfare and Labor, among the four producers in the country, this research center has started production on the 24th. Another one has started on the 20th, the other two producers will start from mid-August. By February next year, it is estimated that total production will be good enough for about 23 million to 30 million people. If too many people want to receive vaccination, the ministry will consider importing more vaccine.

As more and more countries are ready to use vaccination to fight the influenza, it seems that Hong Kong Government has done a right thing in ordering the vaccine some months ago.